Delta Air Lines passenger planes are seen parked due to flight reductions made to slow the spread of coronavirus disease (COVID-19), at Birmingham-Shuttlesworth International Airport in Birmingham, Alabama, March 25, 2020. Elijah Nouvelage | Reuters Delta Air Lines posted a $7 billion pretax loss in the second quarter, driven mostly by the coronavirus pandemic’s devastation on
0 Comments
Jamie Dimon, chief executive officer of JPMorgan Chase & Co. Giulia Marchi | Bloomberg | Getty Images JPMorgan Chase is scheduled to report second-quarter earnings before the opening bell on Tuesday. Here’s what Wall Street expects: Earnings: $1.04 per share, a 63% decline from a year earlier, according to Refinitiv. Revenue: $30.3 billion, 2.5% higher
0 Comments
Tax advisers use the term ‘disclosure’ frequently. Occasionally, taxpayers do too, although they may not understand how or why they or their tax advisers are discussing it. It can sometimes have a negative connotation. Without knowing exactly why, most people do not want to ‘‘disclose’’ unless they must. Discretion and privacy sound better. They may not
0 Comments
In the early 2000s, Tesla Motors was a small start-up underdog in the automotive industry. It faced naysayers because “no one was doing electric cars,” CEO Elon Musk said on the “Third Row Tesla” podcast in February.  But despite the odds, Tesla became the world’s most valuable automaker – its market capitalization surpassed Toyota’s for the first time on July
0 Comments
People volunteer for Covid-19 surveillance testing using the Quest Diagnostics self administered PCR test on on July 12, 2020 in Livingston, Montana. William Campbell | Getty Images Quest Diagnostics reported preliminary second-quarter revenue above analysts’ estimates on Monday, largely on growing demand for its Covid-19 testing services, sending its shares up 2.7% before the bell.
0 Comments
The headquarters of German immunotherapy company BioNTech stands on April 22, 2020 in Mainz, Germany. Thomas Lohnes | Getty Images Check out the companies making headlines midday Monday: Pfizer, BioNTech — Shares of Pfizer and BioNTech jumped 4.4% and 12.6%, respectively, after two experimental coronavirus vaccines jointly developed by the U.S. pharmaceutical giant and German
0 Comments